Key result
Longer-term adherence to supervised exercise training (>36 months) was associated with a 33% lower mortality risk compared with lesser durations (HR 0.67; 95% CI 0.47-0.97; p=0.033).
Why the study?
Does longer-term adherence to supervised exercise training reduce all-cause mortality in participants undertaking exercise-based cardiac rehabilitation?
Cohort (n=435)
Does longer-term adherence to supervised exercise training reduce all-cause mortality in participants undertaking exercise-based cardiac rehabilitation?
Hazard Ratio: 0.67 (95% CI 0.47–0.97)
p-value: p=0.033
Long-term adherence (>36 months) to supervised exercise training in cardiac rehabilitation is associated with a significant reduction in long-term all-cause mortality, whereas exercise dose appears less important.
AIMS: To investigate the relationship between exercise participation, exercise 'dose' expressed as metabolic equivalent (MET) hours (h) per week, and prognosis in individuals attending an extended, community-based exercise rehabilitation programme. METHODS: Cohort study of 435 participants undertaking exercise-based cardiac rehabilitation (CR) in Leeds, West Yorkshire, UK between 1994 and 2006, followed up to 1 November 2013. MET intensity of supervised exercise was estimated utilising serial submaximal exercise test results and corresponding exercise prescriptions. Programme participation was routinely monitored. Cox regression analysis including time-varying and propensity score adjustment was applied to identify predictors of long-term, all-cause mortality across exercise dose and programme duration groups. RESULTS: There were 133 events (31%) during a median follow-up of 14 years (range, 1.2 to 18.9 years). The significant univariate association between exercise dose and all-cause mortality was attenuated following multivariable adjustment for other predictors, including duration in the programme. Longer-term adherence to supervised exercise training (>36 months) was associated with a 33% lower mortality risk (multivariate-adjusted HR: 0.67; 95% CI: 0.47 to 0.97; p=0.033) compared with all lesser durations of CR (3, 12, 36 months), even after adjustment for baseline fitness, comorbidities and survivor bias. CONCLUSION: Exercise dose (MET-h per week) appears less important than long-term adherence to supervised exercise for the reduction of long-term mortality risk. Extended, supervised CR programmes within the community may play a key role in promoting long-term exercise maintenance and other secondary prevention therapies for survival benefit.
No takes yet. Share an insight, caveat, or question.
Taylor et al. (2017) conducted a cohort in Cardiac rehabilitation (n=435). Longer-term adherence to supervised exercise training (>36 months) vs. Lesser durations of cardiac rehabilitation (3, 12, 36 months) was evaluated on All-cause mortality (HR 0.67, 95% CI 0.47 to 0.97, p=0.033). Longer-term adherence to supervised exercise training (>36 months) was associated with a 33% lower mortality risk compared with lesser durations (HR 0.67; 95% CI 0.47-0.97; p=0.033).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: